🔴 Cabaletta Bio is trading 5% down

Cabaletta Bio is trading at $1.82, down 5.44%, with no confirmed company-specific catalyst identified.

• No confirmed October 12 company announcement was found; the latest release located, dated October 5, concerned trial recruitment and inducement grants.
• Coverage mentions an FDA safety investigation into CAR-T therapies, reported in September, but it does not establish the cause of this session’s decline.
• Market indexes showed mixed, relatively modest moves, offering no clear broad-market explanation.